AmerisourceBergen Corporation (ABC): Price and Financial Metrics
AmerisourceBergen Corporation (ABC)
Today's Latest Price: $81.34 USD
Updated Apr 3 12:00am
Add ABC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
ABC Stock Summary
- Amerisourcebergen Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.64% of US listed stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 13.32 for Amerisourcebergen Corp; that's greater than it is for 96.66% of US stocks.
- The volatility of Amerisourcebergen Corp's share price is greater than that of only 0.48% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Amerisourcebergen Corp, a group of peers worth examining would be INTL, XRF, MCK, CVNA, and AMRK.
- Visit ABC's SEC page to see the company's official filings. To visit the company's web site, go to www.amerisourcebergen.com.
ABC Stock Price Chart More Charts
ABC Price/Volume Stats
| Current price | $81.34 | 52-week high | $97.50 |
| Prev. close | $83.89 | 52-week low | $70.55 |
| Day low | $80.39 | Volume | 1,517,200 |
| Day high | $84.62 | Avg. volume | 1,906,785 |
| 50-day MA | $87.87 | Dividend yield | 2.07% |
| 200-day MA | $86.46 | Market Cap | 16.75B |
AmerisourceBergen Corporation (ABC) Company Bio
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.
ABC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $81.34 | $363.32 | 333% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amerisourcebergen Corp. To summarize, we found that Amerisourcebergen Corp ranked in the 72th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 335.33%. As for the metrics that stood out in our discounted cash flow analysis of Amerisourcebergen Corp, consider:
- Its compound free cash flow growth rate, as measured over the past 5.48 years, is 0.34% -- higher than 76.66% of stocks in our DCF forecasting set.
- The weighted average cost of capital for the company is 7. This value is greater than only 17.82% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 325% |
| 1% | 329% |
| 2% | 333% |
| 3% | 337% |
| 4% | 342% |
| 5% | 346% |
Want more companies with a valuation profile/forecast similar to that of Amerisourcebergen Corp? See CVS, ALXN, INVA, BLFS, and CCEL.
Loading social stream, please wait...